InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Monte Rosa Therapeutics, Inc.

GLUE Clue Score47
United States Fiscal year ends December CIK 0001826457 Results filed 5 Nov 2026
Add to watchlist

What the insiders did No buying or selling

By person

10 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Markus Warmuth
President & CEO
—
—
—
585,038
$6.18M
+40.5%
Sharon Townson
Chief Scientific Officer
—
—
—
67,845
$716.44K
—
Jennifer Champoux
Chief Operating Officer
—
—
—
62,371
$658.64K
—
Filip Janku
Chief Medical Officer
—
—
—
60,612
$640.06K
+413.6%
Philip Nickson
Chief Business & Legal Officer
—
—
—
55,000
$580.80K
—
Matthew Bowen
Principal Accounting Officer
—
—
—
25,891
$273.41K
+19.8%
Edmund Dunn
Principal Accounting Officer
—
—
—
22,554
$238.17K
+61.7%
Chandra P. Leo
Director
—
—
—
10,000
$105.60K
—
Ali Behbahani
Director
—
—
—
0
$0.00
−100.0%
Anthony M. Manning
Director
—
—
—
0
$0.00
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.